Abstract
Ameloblastoma, a tumor located in the jaw, grows slowly but locally invasive. Ameloblastoma expands in the jaw based on a mechanism resorbing the surrounding bone. To date, the bone resorption mechanisms of ameloblastoma are associated with the expression of receptor activator of nuclear factor (NF)-κB (RANK) ligand (RANKL), matrix metalloproteinases (MMPs), and tumor necrosis factor (TNF)-α. RANKL plays an important role in generating osteoclastogenesis. MMPs degrade the extracellular matrix. TNF-α can induce the formation of osteoclast and modulate the MMPs. In this review the bone resorption mechanism of ameloblastoma as well its signaling pathway will be disclosed.Keywords: Ameloblastoma, RANKL, MMPs, TNF-α.
Cite
CITATION STYLE
Jackson, J., Halim, J., Anggraeni, R., & Sandra, F. (2021). Bone Resorption in Ameloblastoma and Its Underlying Mechanism. Indonesian Journal of Cancer Chemoprevention, 12(1), 57. https://doi.org/10.14499/indonesianjcanchemoprev12iss1pp57-66
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.